Work

Modelling BCR-ABL1 Dynamics in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) during Frontline Therapy with High-Dose Imatinib, Nilotinib, or Dasatinib.

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.3240.3240

Authors: Adam Olshen, Alfonso Quintαs-Cardama, Hagop M. Kantarjian, Mithat Gonen, Franziska Michor, Jorge Cortes

Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2580679673

FWCI:

Cites:

Cited by:

Related to: 10